acetazolamide has been researched along with Chorea in 7 studies
Acetazolamide: One of the CARBONIC ANHYDRASE INHIBITORS that is sometimes effective against absence seizures. It is sometimes useful also as an adjunct in the treatment of tonic-clonic, myoclonic, and atonic seizures, particularly in women whose seizures occur or are exacerbated at specific times in the menstrual cycle. However, its usefulness is transient often because of rapid development of tolerance. Its antiepileptic effect may be due to its inhibitory effect on brain carbonic anhydrase, which leads to an increased transneuronal chloride gradient, increased chloride current, and increased inhibition. (From Smith and Reynard, Textbook of Pharmacology, 1991, p337)
Chorea: Involuntary, forcible, rapid, jerky movements that may be subtle or become confluent, markedly altering normal patterns of movement. Hypotonia and pendular reflexes are often associated. Conditions which feature recurrent or persistent episodes of chorea as a primary manifestation of disease are referred to as CHOREATIC DISORDERS. Chorea is also a frequent manifestation of BASAL GANGLIA DISEASES.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Clinical details are given of different types of episodic ataxia: type 1, with myokymia, and attacks which usually last a few minutes, and may occur several times a day, and treatment with acetazolamide can reduce the number of attacks; type 2, with interictal nystagmus, and attacks which last for several hours to a day or more, and treatment with acetazolamide is very effective; paroxysmal choreoathetosis with episodic ataxia, with attacks lasting for about 20 min and occurring at varying intervals; and familial hemiplegic migraine, with transient hemiplegia presenting during the aura of a migraine headache, the symptoms improving on treatment with acetazolamide." | 4.80 | Episodic ataxia and channelopathies. ( Gordon, N, 1998) |
| "Acetazolamide was administered to 6 dogs, and 4 dogs experienced a decrease in episode frequency." | 1.56 | Phenotypic characterization of paroxysmal dyskinesia in Maltese dogs. ( Bhatti, SFM; Broeckx, BJG; Charalambous, M; Cornelis, I; Polidoro, D; Santens, P; Van Ham, L, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 2 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Polidoro, D | 1 |
| Van Ham, L | 2 |
| Santens, P | 1 |
| Cornelis, I | 1 |
| Charalambous, M | 1 |
| Broeckx, BJG | 1 |
| Bhatti, SFM | 1 |
| Packer, RA | 1 |
| Wachowiak, I | 1 |
| Thomovsky, SA | 1 |
| Berg, J | 1 |
| Vasquez, L | 1 |
| O'Brien, DP | 1 |
| Royaux, E | 1 |
| Bhatti, S | 1 |
| Harvey, R | 1 |
| Garosi, L | 1 |
| Shelton, GD | 1 |
| Anheim, M | 1 |
| Maillart, E | 1 |
| Vuillaumier-Barrot, S | 1 |
| Flamand-Rouvière, C | 1 |
| Pineau, F | 1 |
| Ewenczyk, C | 1 |
| Riant, F | 2 |
| Apartis, E | 1 |
| Roze, E | 1 |
| Michel, V | 1 |
| Tournier-Lasserve, E | 1 |
| Guehl, D | 1 |
| Lagueny, A | 1 |
| Bioulac, B | 1 |
| Burbaud, P | 1 |
| Gordon, N | 1 |
| Olson, WL | 1 |
2 reviews available for acetazolamide and Chorea
| Article | Year |
|---|---|
Episodic ataxia and channelopathies.
Topics: Acetazolamide; Ataxia; Athetosis; Cerebellar Ataxia; Chorea; Hemiplegia; Humans; Ion Channels; Migra | 1998 |
Acetazolamide relieves concurrent episodic movement disorders encountered in Southern states.
Topics: Acetazolamide; Adult; Anticonvulsants; Athetosis; Chorea; Diagnosis, Differential; Female; Humans; P | 1999 |
5 other studies available for acetazolamide and Chorea
| Article | Year |
|---|---|
Phenotypic characterization of paroxysmal dyskinesia in Maltese dogs.
Topics: Acetazolamide; Animals; Carbonic Anhydrase Inhibitors; Chorea; Diet, Gluten-Free; Dog Diseases; Dogs | 2020 |
Phenotypic characterization of PIGN-associated paroxysmal dyskinesia in Soft-coated wheaten terriers and preliminary response to acetazolamide therapy.
Topics: Acetazolamide; Animals; Chorea; Dog Diseases; Dogs; Female; Homozygote; Male; Mutation; Phenotype; P | 2021 |
Acetazolamide-responsive paroxysmal dyskinesia in a 12-week-old female golden retriever dog.
Topics: Acetazolamide; Animals; Anticonvulsants; Chorea; Dog Diseases; Dogs; Female; Treatment Outcome | 2016 |
Excellent response to acetazolamide in a case of paroxysmal dyskinesias due to GLUT1-deficiency.
Topics: Acetazolamide; Adolescent; Carbonic Anhydrase Inhibitors; Chorea; Female; Glucose Transporter Type 1 | 2011 |
Long-term improvement of paroxysmal dystonic choreathetosis with acetazolamide.
Topics: Acetazolamide; Adolescent; Athetosis; Calcium Channels; Carbonic Anhydrase Inhibitors; Chorea; Dysto | 2006 |